BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | A208683 | SUN PHARMA CANADA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al 1 patentANDA 208683benzoyl peroxide and clindamycin phosphate | D.N.J. | 2017-01-26 | Terminated 2017-04-20 | — |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. TARO PHARMACEUTICALS U.S.A., INC. et al 1 patentANDA 208683benzoyl peroxide and clindamycin phosphate | D.N.J. | 2016-01-12 | Terminated 2018-10-24 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$2.38
per gm
Lowest NADAC/Unit
$2.38
per gm
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 51672140304CLINDAMYC-BNZ PEROX 1.2-3.75% | $2.38 | GM | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.